Please login to the form below

Not currently logged in
Email:
Password:

Merck names head of strategic communications

Julie Gerberding will also have responsibility for global public policy and population health
Merck Julie Gerberding

Merck has named Dr Julie Gerberding as executive vice president for strategic communications, global public policy and population health.

In the newly created position within the executive committee, Gerberding will be responsible for Merck's global public policy, corporate responsibility and communications functions, as well as the Merck Foundation and the Merck for Mothers programme.

She will also lead new partnership initiatives to aid the firm's ability to contribute to improving population health.

Commenting on her appointment, Gerbeding said: “Whether containing the current Ebola outbreak, increasing vaccination rates or improving the overall health of people in communities, partnerships between public and private sector organisations are essential.

“Merck has a unique role and a responsibility to contribute and I welcome this opportunity to lead teams of experts who will help us achieve our mission of saving lives and improving health around the world.”

Gerberding joined Merck as president of Merck Vaccines in January 2010. Prior to this role, she served as director of the US Centers for Disease Control and Prevention from 2002 and was director of the Division of Healthcare Quality Promotion before that.

Kenneth Frazier, chairman and CEO of Merck, said: “Julie's leadership of our vaccines business and her exceptional track record in both the public and private sectors make her ideally suited to lead these areas and to advance our engagement with organisations around the world that, like Merck, are working to advance population health.”

16th December 2014

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....